Affiliation:
1. PriceSpective, Los Angeles, CA
Abstract
To improve formulary design processes and support payers in providing more effective health care, policy makers should consider involving commercial payers in the development of comparative effectiveness research and creation of research and treatment guidelines.
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Health Policy,Oncology(nursing),Oncology
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献